FDA strengthens existing warning on Morcellators

Posted on Monday, November 24th, 2014 at 2:47 pm    

Today, the FDA strengthened an existing warning about the dangers posed by power morcellators. These devices, which have come under heavy scrutiny in recent months, had previously been a common surgical tool used in hysterectomies and in the removal of uterine fibroids. Unfortunately, these devices pose an immense threat as they have the ability to spread undetected uterine cancer to other parts of the body.

Because of these dangers, the FDA issued a warning in April 2014 discussing the potential risk associated with these devices. However, this warning was updated and strengthened today, as the FDA noted that for the removal of fibroids and in hysterectomies, these devices should not be used in “the vast majority of women.” To help protect patients, the FDA has recommended that a boxed warning be added to detail the dangers of the devices. The agency has also mentioned two specific situations in which these devices should never be used; however, these two instances cover the vast majority of situations in which the use of a power morcellator may have been appropriate.

When the FDA issued their initial warning earlier this year, medical device manufacturer Johnson & Johnson recalled three of their popular power morcellators, and advised medical professionals to stop utilizing these devices in procedures.

Today’s FDA announcement can be read in full by clicking here.


Two Florida universities to study Gulf of Mexico oil spill

Posted on Monday, November 24th, 2014 at 1:27 pm    

The University of Miami Rosenstiel School of Marine and Atmospheric Science and the Nova Southeastern University, two universities in South Florida, have recently received $29 million and $8.5 million, respectively, to study the effects of the Gulf of Mexico oil spill which occurred when London-based oil giant BP Plc’s oil rig exploded back in 2010.

The money is included in the $500 million, 10-year independent research program that BP initiated in May 2010 as part of its cleanup efforts.

The explosion of BP’s Deepwater Horizon oil rig in the Gulf of Mexico on April 20, 2010 claimed the life of 11 workers and spilled over 200 million gallons of oil within a period of 87 days, making the event the biggest oil spill the U.S. has ever experienced. The environment and related businesses are still recovering.

If you are looking to file a BP Gulf of Mexico oil spill claim, entrust your cause with our attorneys at the Williams Kherkher Law Group and contact one of our knowledgeable and experienced lawyers by dialing (800) 220-9341 today.


Qysmia’s adverse effects on cognition

Posted on Thursday, November 20th, 2014 at 1:36 pm    

Qysmia is a newly-approved weight-loss medicine that contains two active ingredients: appetite suppressant Phentermine and the anticonvulsant drug Topiramate. Together, the two drugs work hand-in-hand to create a feeling of increased satiety and decreased appetite.

Over the years, however, Qysmia has been associated with cases of compromised cognitive processes among individuals who took it. Some researchers believe Qysmia’s cognitive effects are caused by Topiramate. In a 2010 study published by the Journal of Neurology, Neurosurgery, and Psychiatry, scientists found out that using Topiramate may decrease verbal IQ, verbal fluency, and verbal learning, while withdrawing or reducing its dose resulted in improvements.

But although Qymsia’s cognitive effects could be reversible, one-year controlled trials of the drug revealed a number of patients still experienced effects, some of longer duration, even after Qysmia treatment. If you have been suffering from any cognitive disorder while or after taking Qysmia, consult with an attorney at Williams Kherkher to learn which legal steps are available in seeking justice and compensation. Call us at (800) 220-9341 today.


Surviving ovarian cancer

Posted on Thursday, November 20th, 2014 at 1:24 pm    

Ovarian cancer occurs when malignant cells develop and multiply in one or both ovaries. Considered the 5th deadliest cancer among women, ovarian cancer usually affects women aged 55 to 64 years old. Furthermore, some cases of ovarian cancer have been associated with women’s use of talc-based powders on their genitals.

Through its Surveillance, Epidemiology, and End Result (SEER) program, the National Cancer Institute found that women battling against ovarian cancer had a 44.6% chance of survival within the first five years. With early detection, proper medical care, and a shift to a healthier lifestyle, women with ovarian cancer may successfully win over this dreaded disease.

If you believe your cancer has resulted from using talcum powder products, our team of product liability attorneys at Williams Kherkher can assess your situation for free. Call us now at (800) 220-9341 if you are considering filing a legal claim against the manufacturers responsible.


The dangers of pancreatitis

Posted on Thursday, November 20th, 2014 at 1:10 pm    

Pancreatitis, or the inflammation of the pancreas, happens when the digestive enzymes inside your pancreas become activated before being released into the small intestine to aid in digestion. The activated enzymes will then irritate the cells and the tissues of the pancreas, causing the organ to be inflamed.

If pancreatitis is left untreated, serious medical complications may occur. These may include:

  • Infection – The inflamed organ makes it vulnerable to infectious agents
  • Pancreatic cancer – Persistent pancreatitis is considered one of pancreatic cancer’s risk factors
  • Diabetes – Disorders of the pancreas may result in a compromised production of insulin, a hormone important in regulating the levels of sugar in the blood
  • Malnutrition – Pancreatitis may lead to lower production of pancreatic juice necessary in digesting fats, proteins and carbohydrates

Unfortunately, the risk of pancreatitis is higher among individuals who are taking the anti-psychotic drug Risperdal. If taking this drug has compromised your health in any way, learn about your options to file a lawsuit against the manufacturer involved. Consult with an attorney at Williams Kherkher by calling 800-220-9341 today.


Further investigation into La Porte DuPont plant reveals multiple violations

Posted on Wednesday, November 19th, 2014 at 2:53 pm    

Over the weekend, a chemical leak at a DuPont plant killed four workers. While the plant had been cited previously for safety violations, federal inspectors hadn’t inspected the facility since 2007. The 2007 inspection, performed by inspectors from the Occupational Safety and Health Administration (OSHA), cited four serious safety violations, including violations of safe management for hazardous chemicals.

In the chemical leak this past weekend, an estimated 100 pounds of methyl mercaptan leaked throughout the plant. Unfortunately, even the smallest amount of exposure can be fatal. It has since been discovered that this toxic chemical leak was caused by a faulty valve.

The Environmental Protection Agency (EPA) also brought formal enforcement actions against the DuPont plant for 2012 and 2014 violations that cost the plant $117,375 in penalties.

DuPont stated that they are taking steps to make sure the area is safe to access. With regards to the multiple safety violations, DuPont states they “are committed to meeting or exceeding all applicable state and federal regulatory requirements.”


Medications that can increase bleeding risks of people taking Xarelto

Posted on Wednesday, November 19th, 2014 at 10:25 am    

Patients taking Xarelto have an increased risk of serious bleeding that can be fatal, especially when combined with other medicines, including the following:

• Warfarin sodium drugs like Jantoven and Coumadin
• Any medicine containing aspirin or heparin
• Non-steroidal anti-inflammatory drugs
• Medicines that contain “Clopidogrel” to inhibit blood clots

Patients planning to take Xarelto are advised to tell their physician if they are taking any of the medications mentioned above or any other medications that they are currently using. Be sure to also inform your physician of any existing bleeding related conditions.

Unfortunately some Xarelto users suffer serious prolonged and uncontrollable gastrointestinal bleeding. If you or someone you know taking Xarelto has experienced this, treatment funds may be awarded to you to recover your loss. Consult with us today about your situation with the legal team of Williams Kherkher at (800) 220-9341 to find out how we may help you pursue claims against negligent drug makers.


How Benicar helps reduce high blood pressure

Posted on Wednesday, November 19th, 2014 at 10:07 am    

Benicar reduces the risk of complications from high blood pressure by introducing the active ingredient “olmesartan” into the body.

Benicar and its counterpart, hydrochlorothiazide (HCT), both work to obstruct the naturally occurring chemical angiotensin II, which is partially responsible for increasing blood pressure. Blocking this chemical relaxes and widens the blood vessels. Benicar HCT additionally reduces the body’s water content that can also cause blood pressure to increase. Clinical studies revealed that patients taking this medication will decrease their blood pressure for 24 hours, and if taken regularly as prescribed by doctors it will continue reduce blood pressure for up to one year.

Though Benicar works to decrease the chance of cardiovascular problems in patients by reducing high blood pressure, serious or even fatal intestinal side effects can occur. If you or a loved one have experienced this, the legal team of Williams Kherkher may help you figure out if you are entitled to receive remunerations for your treatment. Call our office today at (800) 220-9341 to find out how we may help you seek compensation from using this potentially hazardous drug.


Promising new melanoma treatment drug – University of Colorado study

Posted on Wednesday, November 19th, 2014 at 9:16 am    

A University of Colorado Cancer Study Center study that was recently published in the journal Molecular Cancer Therapeutics showed that a new melanoma drug, the experimental TAK-733, has been successful in generating anti-cancer activity in 10 out of 11 mice treated with it, Drug Discovery and Development reported on November 12.

CU School of Medicine associate professor and CU Cancer Center investigator John Tentler, PhD, gave further credibility to the study by noting that patient-derived xenographs were used, meaning the melanoma samples given to the mice were from human patients affected by the disease. This has been prove to give a more accurate reading on how well drugs will work on humans.

There are around 1 million people in the United States who are currently suffering from melanoma, statistics from the National Cancer Institute showed.

Melanoma cell invasion has been purported to be brought about by the use of the male fertility drug Viagra. If you should develop this illness and you attribute it to your Viagra use, get in touch with our attorneys at Williams Kherkher to gain legal assistance by dialing 800-220-9341 today.


Shame and silence plagues those with hypospadias

Posted on Tuesday, November 18th, 2014 at 2:55 pm    

Mail Online discusses the emotional toll that is often a result for those diagnosed with hypospadias.

Hypospadias is a birth defect where the urethral opening is at an abnormal spot. Some men interviewed said they feel alone and isolated, despite the relative prevalence of this disorder (affecting one out of every 300 men)  due to the reluctance of many to discuss their condition. Data of pediatric urological surgeons revealed that from 1999 up to 2010, 14.5 percent children with hypospadias have undergone a minimum of three surgeries to attempt to correct the defect. James Newman, who has undergone 19 surgical procedures to correct his hypospadias, suffered complications and eventually developed post-traumatic stress disorder. Though surgery is a common option, some are now advocating for a non-surgical option.

The incidence of hypospadias is growing; this may be due to exposure to defective pharmaceuticals like Topamax in the womb. The lawyers of Williams Kherkher know that many men suffer physical and emotional consequences from hypospadias. Discuss your case with us today in confidence at (800) 220-9341 to see if we may be able to hold negligent parties responsible.


1 2 3 39

Williams Kherkher   |   8441 Gulf Fwy #600   |   Houston, TX 77017   |   Phone: (713) 230-2200   |   Toll Free: (800) 220-9341   |   Directions   |